After leading the first in a series of class actions by thousands of junior doctors to victory at trial, the applicant in a landmark wage case against Peninsula Health has told a judge the penalty against the Victorian hospital operator must send a clear message.
A judge has struck out an allegation by the builder of Sydney’s Opal Tower that insurer Liberty Mutual breached its duty of good faith and has warned Icon to carefully consider whether to re-plead the claim.
A Gadens-led class action against former Quintis director Frank Wilson has settled, but a second class action filed by a rival firm has flagged a potential claim on the settlement funds over a cause of action said to have been “picked up parasitically”.
Plaintiff firm Maurice Blackburn will foot the bill for the unsuccessful class action against Monsanto over weed killer Roundup, but the company’s reluctance to split the trial in two has come back to bite it.
A contradictor has argued against Monash IVF’s bid for orders allowing it to retain embryos as evidence in a class action, saying the Victorian Supreme Court has no power to make orders inconsistent with the company’s statutory obligation to store embryos for a maximum of five years.
In submissions to the High Court, the applicant in a class action brought on behalf of Arrium shareholders against KMPG has attacked the Attorney-General’s argument that a contingency fee order is a neutral factor in assessing the accounting firm’s bid to move the case from Victoria.
Experts say the chaos of last month’s CrowdStrike outage is likely to spark a flurry of litigation both overseas and at home, including class actions, but lawyers bringing the claims will face significant hurdles.
A law firm is investigating claims against the manufacturers of popular heartburn and acid reflux drugs, alleging they could be responsible for causing stomach cancers and kidney failure in approximately 100,000 people.
In the first-ever settlement approval hearing involving a group costs order, a contradictor has argued that Slater & Gordon should have provided the court with more information on legal costs and internal rate of return as part of its bid for a $12.8 million contingency fee.
A judge has dismissed a class action alleging Monsanto’s Roundup weed killer is carcinogenic but did not go so far as to say it definitively does not cause cancer, while also dressing down the lawyers for both sides for causing delays in the case.